Cargando…
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
SIMPLE SUMMARY: Radiofrequency ablation (RFA) is a curative treatment for early-stage hepatocellular carcinoma (HCC) ineligible for surgery or liver transplantation. However, trans-arterial chemoembolization (TACE) might be an alternative when RFA is contraindicated due to structural problems. Among...
Autores principales: | Yun, Byung-Yoon, Lee, Hye Won, Min, In Kyung, Kim, Seung Up, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Beom Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565721/ https://www.ncbi.nlm.nih.gov/pubmed/32899584 http://dx.doi.org/10.3390/cancers12092527 |
Ejemplares similares
-
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
por: Park, Yehyun, et al.
Publicado: (2019) -
Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
por: Lee, Sang Hoon, et al.
Publicado: (2015) -
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Kim, Chang Gon, et al.
Publicado: (2019) -
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Kim, David Sooik, et al.
Publicado: (2021) -
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
por: Kim, Yuna, et al.
Publicado: (2021)